Skip to main content
Shedir Pharma Group logo

Shedir Pharma Group — Investor Relations & Filings

Ticker · SHE ISIN · IT0005379620 LEI · 81560092B300849E9017 XMIL Manufacturing
Open in API
Filings indexed 124 across all filing types
Latest filing 2021-04-29 AGM Information
Country IT Italy
Listing XMIL SHE

About Shedir Pharma Group

https://www.shedirpharmagroup.com

Shedir Pharma Group specializes in the research, development, formulation, and commercialization of health and wellness products. The company's portfolio encompasses nutraceuticals, dermocosmetics, medical devices, and pharmaceuticals. A key focus is on innovation, resulting in the creation of unique and patented product formulations that cover approximately 15 therapeutic areas. The group operates through specialized subsidiaries that manage the entire product lifecycle, from initial research and intellectual property to marketing and distribution. Products are offered in various forms, such as capsules, tablets, powders, liquids, and gels, targeting professionals in the medical and pharmaceutical sectors.

Recent filings

Filing Released Lang Actions
Assemblea ordinaria e straordinaria degli Azionisti del 29 aprile 2021
AGM Information Classification · 99% confidence The document is an official communication (Informazione Regolamentata) dated April 29, 2021, detailing the outcomes of the Ordinary and Extraordinary Shareholders' Meeting (Assemblea Ordinaria e Straordinaria). The content covers the approval of the 2020 Financial Statements, dividend distribution, board/statutory auditor appointments, and statutory amendments. Since the document reports the results and decisions made during a general meeting, it is directly related to the proceedings of that meeting. While it contains financial results (like the 2020 profit), its primary function is reporting the meeting's resolutions. The closest fit among the provided codes is AGM-R (AGM Information), as the meeting described is an 'Assemblea' (General Meeting), which typically encompasses the Annual General Meeting (AGM) functions like approving annual accounts and dividends. It is not a general Earnings Release (ER) or a comprehensive Interim Report (IR), but a record of shareholder decisions.
2021-04-29 Italian
Certificazione come dispositivi medici di classe IIA per i prodotti della Linea Rinoair® e Flubexin®
Regulatory Filings Classification · 95% confidence The document is an official communication from Shedir Pharma Group S.p.A., identified by the header 'Informazione Regolamentata' and the 'Oggetto' (Subject) detailing the certification of medical devices. The text is a press release ('COMUNICATO STAMPA') announcing a specific operational achievement (obtaining Class IIA medical device certification for product lines). This type of announcement, which details a specific business event or operational update rather than comprehensive financial results (10-K, IR) or management changes (MANG), fits best under the general category for regulatory announcements that are not otherwise specified. Since it is a specific operational update and not a standard financial report, and it is not a proxy statement, dividend notice, or insider trade, the most appropriate classification is Regulatory Filings (RNS), which serves as a broad category for official, non-standard announcements.
2021-04-28 Italian
Avviso di deposito della Relazione Finanziaria Annuale 2020 e della documentazione assembleare
Report Publication Announcement Classification · 99% confidence The document is an official notice from Shedir Pharma Group S.p.A. titled "Avviso di deposito della Relazione Finanziaria Annuale 2020 e della documentazione assembleare" (Notice of filing of the 2020 Annual Financial Report and assembly documentation). The text explicitly states that the Annual Financial Report (Relazione Finanziaria Annuale), management report, audit reports, and assembly documentation are being made available to the public and on the company website. This structure—a short announcement detailing the availability of a major report—fits the definition of a Report Publication Announcement (RPA), rather than the full Annual Report (10-K) itself. The document length (5699 chars) is also consistent with a brief announcement.
2021-04-14 Italian
Pubblicazione dell’Avviso di Convocazione dell’Assemblea Ordinaria e Straordinaria degli Azionisti di Shedir Pharma Group S.p.A.
AGM Information Classification · 99% confidence The document is an official notice titled "CONVOCAZIONE DELL'ASSEMBLEA ORDINARIA E STRAORDINARIA DEGLI AZIONISTI" (Notice of Convocation of the Ordinary and Extraordinary Shareholders' Meeting). It details the date, time, and agenda for a shareholders' meeting, including items like the approval of the 2020 financial statements, dividend distribution, and amendments to the bylaws. This content directly relates to the formal proceedings and materials associated with an Annual General Meeting (AGM). Although it mentions the availability of the financial statements, the primary purpose of this specific document is the formal call for the meeting itself, which aligns best with the 'AGM Information' category, as it is the official notice/convocation for the AGM.
2021-04-14 Italian
Shedir Pharma Group S.p.A. - Comunicato Stampa Bilancio d'esercizio e consolidato al 31 dicembre 2020
Earnings Release Classification · 98% confidence The document is explicitly titled 'Comunicato Stampa Bilancio d'esercizio e consolidato al 31 dicembre 2020' (Press Release Annual and Consolidated Financial Statements as of December 31, 2020). It contains key financial highlights (Revenues, EBITDA, Net Income, Net Financial Position) for the year ended December 31, 2020, and mentions the approval of the draft financial statements by the Board of Directors. This content structure—a press release summarizing annual financial results—aligns perfectly with the definition of an Earnings Release (ER), which is the initial announcement of periodical financial results. Although it discusses the full year, the format is a press release summary, not the comprehensive 10-K filing itself. Furthermore, it announces the upcoming Shareholders' Meeting to approve the financial statements, which is typical for an ER preceding the formal AGM/10-K filing. FY 2020
2021-03-29 Italian
Shedir Pharma Group S.p.A. - Nomina del nuovo Consigliere Esecutivo
Board/Management Information Classification · 99% confidence The document is an official communication ('Informazione Regolamentata') from Shedir Pharma Group S.p.A. The subject ('Oggetto') explicitly states: 'Shedir Pharma Group S.p.A. - Nomina del nuovo Consigliere Esecutivo' (Appointment of the new Executive Director). The text details the co-optation of Dr. Pierfrancesco Maschio to the Board of Directors, replacing a resigned member. This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2021-01-29 Italian

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.